Table 2.
Visual Acuity Over Time of Ebola Survivors and Controls Following MSICS
| Ebola Survivors (n = 22 Eyes) | Controls (n = 12 Eyes) | Overall (N = 34 Eyes) | P | |
|---|---|---|---|---|
| Visual acuity (20/x), median [mean] (Q1, Q3) | Ebola survivors vs. controls, overall: P = 0.067 | |||
| Baseline | 200 [2286] (72, 4000) | 1400 [3331] (145, 5500) | 800 [2655] (100, 4000) | |
| 1 month postoperative | 28 [215] (25, 40) | 50 [384] (40, 63) | 40 [275] (25, 50) | |
| 1 year postoperative | 25 [158] (25, 32) | 50 [374] (30, 53) | 32 [237] (25, 50) | Baseline vs. year 1, overall: P < 0.001 |
| Number of lines of improvement, median [mean] (Q1, Q3) | Ebola survivors vs. controls: P < 0.465 | |||
| Baseline to 1 year postoperative | 7.96 [10.9] (4.01, 20.97) | 13.97 [12.15] (4.79, 17.55) | 8.06 [11.36] (4.01, 20.97) | |
| Spherical equivalent refractive error, mean ± SD | ||||
| 1 month postoperative | –1.39 ± 1.23 | 0.64 ± 3.46 | –0.7 ± 2.41 | |
| 1 year postoperative | –1.82 ± 1.01 | –1.67 ± 2.51 | –1.76 ± 1.75 | |
Visual acuity at 1 year relative to baseline was significantly higher across all participants (P < 0.001); the difference between survivors and controls was not significant (P = 0.067).